Business
‘Going to take some time’: ResMed patient on global vaccine rollout – Sydney Morning Herald
The medical device maker has seen an easing in COVID-19-driven demand for its ventilators and is now banking on a recovery of its core business of sleep apnea products….
As vaccinations roll out and countries start to open up again, we expect healthcare to recover. But its going to take some time, he said.
ResMed shares rallied over the course of 2020 as the business sold hundreds of millions of dollars worth of its ventilators into hospitals across the world struggling to cope with the coronavirus pandemic. The sales boom bumped its revenues up by $US40 million last quarter alone.
In a call to investors on Friday morning, Mr Farrell and his management team said…
-
General22 hours agoJannik Sinner reveals secret Wimbledon bet that could keep Darren Cahill in his team
-
General23 hours agoResearchers map key north-south divide in Australia’s orca population
-
Business23 hours agoASX retail share whose ‘fundamentals have deteriorated significantly’: expert
-
Noosa News23 hours agoInterventions not just tool for regulators – Proctor